L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Posted ContentDOI
Risk prediction with office and ambulatory blood pressure using artificial intelligence
Pedro Guimarães,Andreas Keller,Michael Böhm,Lucas Lauder,José L. Ayala,José R. Banegas,Alejandro de la Sierra,Ernest Vinyoles,Manuel Gorostidi,Julian Segura,Gema Ruiz-Hurtado,Luis M. Ruilope,Felix Mahfoud +12 more
TL;DR: The authors have withdrawn this manuscript because they became aware of inaccuracies on the original raw data.
Journal ArticleDOI
Recent advances in the management of hypertension.
TL;DR: In summary, a low BP goal when cardiorenal disease is advanced can be risky, however, attaining normal BP levels at earlier stages in the cardiorespiratory continuum is probably totally adequate.
Journal ArticleDOI
Twenty-four hour ambulatory blood pressure monitoring in patients with stable heart failure. Prevalence and associated factors.
Adriana Rodríguez Chaverri,Pedro Caravaca Pérez,Fernando Aguilar-Rodríguez,Sonia Mirabet Perez,M. L. Lopez,Javier De la Cruz,Jose M. Guerra,Julian Segura,Fernando Arribas Ynsaurriaga,Luis M. Ruilope,Juan F. Jimenez +10 more
TL;DR: In this paper , a cross-sectional observational study of patients with optimized stable chronic heart failure (HF) was conducted, where patients underwent blood pressure (BP) measurement in the office and 24-hour ambulatory monitoring.
Journal ArticleDOI
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE.
Felix Mahfoud,Giuseppe Mancia,Roland E. Schmieder,Luis M. Ruilope,Krzysztof Narkiewicz,Markus P. Schlaich,Bryan Williams,Flavio Ribichini,Joachim Weil,Khaled Almerri,Faisal Sharif,Lucas Lauder,M. Wanten,Martin Fahy,Michael Böhm +14 more
TL;DR: In this paper , the authors evaluated whether the number or type of antihypertensive medications were associated with increased long-term blood pressure (BP) reductions and cardiovascular outcomes following radiofrequency RDN.
Journal ArticleDOI
The Clinical Significance of Blood Pressure Lowering Treatment: First-Line Drug Choice is Important
TL;DR: An adequate risk stratification is necessary in each hypertensive patient followed by an intervention that not only lowers blood pressure, but can also improve other aspects of the cardiorenal disease that so frequently accompany arterial hypertension.